Impact of statin usage patterns on outcomes after percutaneous coronary intervention in acute myocardial infarction: Korea Working Group on Myocardial Infarction registry (KorMI) study

Journal of Geriatric Cardiology

Volumn 11, Issue 2, 2014, Pages 93-99

  Lee, Chan Hee ^a   Lee, Sang Hee ^a   Park, Jong Seon ^a   Kim, Young Jo ^a   Kim, Kee Sik ^b   Chae, Shung Chull ^c   Kim, Hyo Soo ^d   Choi, Dong Ju ^e   Cho, Myeong Chan ^f   Rha, Seung Woon ^g   Jeong, Myung Ho ^h  

^a Young Nam University Hospital   (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Chungbuk National University Hospital   (South Korea)

^g Korea University College of Medicine   (South Korea)

^h Chonnam National University Medical School   (South Korea)

Author keywords

Keywords: Statins; acute myocardial infarction; treatment outcome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84904464083     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2014.02.010     Document Type: Article

References (23)

1. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
2. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008; 118: 2596-2648.
3. De Luca G, Suryapranata H, Zijlstra F, et al. Statin therapy and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Neth Heart J 2004; 12: 271-278.
4. Daskalopoulou SS, Delaney JA, Filion KB, et al. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J 2008; 29: 2083-2091.
5. Kadota S, Matsuda M, Izuhara M, et al. Long-term effects of early statin therapy for patients with acute myocardial infarction treated with stent implantation. J Cardiol 2008; 51: 171-178. (Pubitemid 351718488)
6. Wassmann S, Faul A, Hennen B, et al. Rapid effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res 2003; 93: e98-e103.
7. Sanguigni V, Pignatelli P, Lenti L, et al. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 2005; 111: 412-419. (Pubitemid 40204424)
8. Suzuki G, Iyer V, Cimato T, et al. Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res 2009; 104: 255-264.
9. Liao Y, Zhao H, Ogai A, et al. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation. Hypertens Res 2008; 31: 335-344. (Pubitemid 351461114)
10. Tang Q, Huang J, Qian H, et al. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization. Life Sci 2007; 80: 601-608. (Pubitemid 46098934)
11. Di Napoli P, Taccardi AA, Grilli A, et al. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc Res 2005; 66: 462-471. (Pubitemid 40725758)
12. Celik T, Kursaklioglu H, Iyisoy A, et al. The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction. Coron Artery Dis 2005; 16: 321-326. (Pubitemid 41073302)
13. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-436. (Pubitemid 32097261)
14. Lenderink T, Boersma E, Gitt AK, et al. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on Acute Coronary Syndromes. Eur Heart J 2006; 27: 1799-1804. (Pubitemid 44297384)
15. Armitage J. The safety of statins in clinical practice. Lancet 2007; 370: 1781-1790. (Pubitemid 350137473)
16. Lee DS, Tu JV, Juurlink DN, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005; 294: 1240-1247. (Pubitemid 41352112)
17. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004; 291: 1864-1870. (Pubitemid 38509499)
18. Hoogerbrugge N, van Domburg R, van der Zwet E, et al. High fat intake in hyperlipidaemic patients is related to male gender, smoking, alcohol intake and obesity. Neth J Med 2001; 59: 16-22. (Pubitemid 32611582)
19. De Luca G, Suryapranata H, Ottervanger JP, et al. Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Atherosclerosis 2006; 189: 186-192. (Pubitemid 44441280)
20. Cubeddu LX, Seamon MJ. Statin withdrawal: clinical implications and molecular mechanisms. Pharmacotherapy 2006; 26: 1288-1296. (Pubitemid 44306889)
21. Fonarow GC, Wright RS, Spencer FA, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005; 96: 611-616. (Pubitemid 41207298)
22. Spencer FA, Fonarow GC, Frederick PD, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction. Arch Intern Med 2004; 164: 2162-2168. (Pubitemid 39410807)
23. McGowan MP. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 2004; 110: 2333-2335. (Pubitemid 39407335)